Cross-resistance of isoniazid, para-aminosalicylic acid and pasiniazid against isoniazid-resistant Mycobacterium tuberculosis isolates in China
Objectives: Pasiniazid is a chemical complex of isoniazid (INH) and para-aminosalicylic acid (PAS). The aim of this study was to explore the cross-resistance of INH, PAS and pasiniazid against INH-resistant Mycobacterium tuberculosis isolates in China. Methods: A Microplate alamarBlue® Assay was per...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-03-01
|
Series: | Journal of Global Antimicrobial Resistance |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213716519302036 |
id |
doaj-a5eb65b5e5404a489f77966e4f0f8969 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Guilian Li Jingrui Zhang Yi Jiang Li-li Zhao Haican Liu Machao Li Xiuqin Zhao Kanglin Wan |
spellingShingle |
Guilian Li Jingrui Zhang Yi Jiang Li-li Zhao Haican Liu Machao Li Xiuqin Zhao Kanglin Wan Cross-resistance of isoniazid, para-aminosalicylic acid and pasiniazid against isoniazid-resistant Mycobacterium tuberculosis isolates in China Journal of Global Antimicrobial Resistance Cross-resistance Mycobacterium tuberculosis Isoniazid Pasiniazid Para-aminosalicylic acid |
author_facet |
Guilian Li Jingrui Zhang Yi Jiang Li-li Zhao Haican Liu Machao Li Xiuqin Zhao Kanglin Wan |
author_sort |
Guilian Li |
title |
Cross-resistance of isoniazid, para-aminosalicylic acid and pasiniazid against isoniazid-resistant Mycobacterium tuberculosis isolates in China |
title_short |
Cross-resistance of isoniazid, para-aminosalicylic acid and pasiniazid against isoniazid-resistant Mycobacterium tuberculosis isolates in China |
title_full |
Cross-resistance of isoniazid, para-aminosalicylic acid and pasiniazid against isoniazid-resistant Mycobacterium tuberculosis isolates in China |
title_fullStr |
Cross-resistance of isoniazid, para-aminosalicylic acid and pasiniazid against isoniazid-resistant Mycobacterium tuberculosis isolates in China |
title_full_unstemmed |
Cross-resistance of isoniazid, para-aminosalicylic acid and pasiniazid against isoniazid-resistant Mycobacterium tuberculosis isolates in China |
title_sort |
cross-resistance of isoniazid, para-aminosalicylic acid and pasiniazid against isoniazid-resistant mycobacterium tuberculosis isolates in china |
publisher |
Elsevier |
series |
Journal of Global Antimicrobial Resistance |
issn |
2213-7165 |
publishDate |
2020-03-01 |
description |
Objectives: Pasiniazid is a chemical complex of isoniazid (INH) and para-aminosalicylic acid (PAS). The aim of this study was to explore the cross-resistance of INH, PAS and pasiniazid against INH-resistant Mycobacterium tuberculosis isolates in China. Methods: A Microplate alamarBlue® Assay was performed to determine the minimum inhibitory concentrations (MICs) of INH, PAS and pasiniazid against 109 INH-resistant M. tuberculosis isolates. A statistical analysis of the relationship between different genotypes, gene mutations, and INH, PAS or pasiniazid susceptibility was then performed. Results: Among the 109 INH-resistant isolates, 13 (11.9%) and 21 (19.3%) showed resistance to PAS and pasiniazid, respectively. Among the 13 PAS-resistant M. tuberculosis isolates, 11 remained susceptible to pasiniazid. Of 63 INH-resistant isolates harbouring mutations in katG, the inhA promoter or the oxyR–ahpC intergenic region, 52 remained susceptible to pasiniazid. Moreover, 11 of 13 pasiniazid-resistant isolates carried mutations in katG, the inhA promoter or the oxyR–ahpC intergenic region. Conclusion: Taken together, these results demonstrate that PAS resistance and mutations in thekatG gene, inhA promoter or oxyR–ahpC intergenic region in INH-resistant M. tuberculosis have little effect on pasiniazid susceptibility. |
topic |
Cross-resistance Mycobacterium tuberculosis Isoniazid Pasiniazid Para-aminosalicylic acid |
url |
http://www.sciencedirect.com/science/article/pii/S2213716519302036 |
work_keys_str_mv |
AT guilianli crossresistanceofisoniazidparaaminosalicylicacidandpasiniazidagainstisoniazidresistantmycobacteriumtuberculosisisolatesinchina AT jingruizhang crossresistanceofisoniazidparaaminosalicylicacidandpasiniazidagainstisoniazidresistantmycobacteriumtuberculosisisolatesinchina AT yijiang crossresistanceofisoniazidparaaminosalicylicacidandpasiniazidagainstisoniazidresistantmycobacteriumtuberculosisisolatesinchina AT lilizhao crossresistanceofisoniazidparaaminosalicylicacidandpasiniazidagainstisoniazidresistantmycobacteriumtuberculosisisolatesinchina AT haicanliu crossresistanceofisoniazidparaaminosalicylicacidandpasiniazidagainstisoniazidresistantmycobacteriumtuberculosisisolatesinchina AT machaoli crossresistanceofisoniazidparaaminosalicylicacidandpasiniazidagainstisoniazidresistantmycobacteriumtuberculosisisolatesinchina AT xiuqinzhao crossresistanceofisoniazidparaaminosalicylicacidandpasiniazidagainstisoniazidresistantmycobacteriumtuberculosisisolatesinchina AT kanglinwan crossresistanceofisoniazidparaaminosalicylicacidandpasiniazidagainstisoniazidresistantmycobacteriumtuberculosisisolatesinchina |
_version_ |
1721434457571852288 |
spelling |
doaj-a5eb65b5e5404a489f77966e4f0f89692021-05-20T07:48:39ZengElsevierJournal of Global Antimicrobial Resistance2213-71652020-03-0120275281Cross-resistance of isoniazid, para-aminosalicylic acid and pasiniazid against isoniazid-resistant Mycobacterium tuberculosis isolates in ChinaGuilian Li0Jingrui Zhang1Yi Jiang2Li-li Zhao3Haican Liu4Machao Li5Xiuqin Zhao6Kanglin Wan7Tuberculosis Branch, State Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, ChinaTuberculosis Branch, State Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China; Laboratory, Shijiazhuang Obstetrics and Gynecology Hospital, the Fourth Hospital of Shijiazhuang, Shijiazhuang, Hebei 050000, ChinaTuberculosis Branch, State Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, ChinaTuberculosis Branch, State Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, ChinaTuberculosis Branch, State Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, ChinaTuberculosis Branch, State Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, ChinaTuberculosis Branch, State Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, ChinaTuberculosis Branch, State Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China; Corresponding author. Present address: National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, P.O. Box 5, Changping, Beijing 102206, China.Objectives: Pasiniazid is a chemical complex of isoniazid (INH) and para-aminosalicylic acid (PAS). The aim of this study was to explore the cross-resistance of INH, PAS and pasiniazid against INH-resistant Mycobacterium tuberculosis isolates in China. Methods: A Microplate alamarBlue® Assay was performed to determine the minimum inhibitory concentrations (MICs) of INH, PAS and pasiniazid against 109 INH-resistant M. tuberculosis isolates. A statistical analysis of the relationship between different genotypes, gene mutations, and INH, PAS or pasiniazid susceptibility was then performed. Results: Among the 109 INH-resistant isolates, 13 (11.9%) and 21 (19.3%) showed resistance to PAS and pasiniazid, respectively. Among the 13 PAS-resistant M. tuberculosis isolates, 11 remained susceptible to pasiniazid. Of 63 INH-resistant isolates harbouring mutations in katG, the inhA promoter or the oxyR–ahpC intergenic region, 52 remained susceptible to pasiniazid. Moreover, 11 of 13 pasiniazid-resistant isolates carried mutations in katG, the inhA promoter or the oxyR–ahpC intergenic region. Conclusion: Taken together, these results demonstrate that PAS resistance and mutations in thekatG gene, inhA promoter or oxyR–ahpC intergenic region in INH-resistant M. tuberculosis have little effect on pasiniazid susceptibility.http://www.sciencedirect.com/science/article/pii/S2213716519302036Cross-resistanceMycobacterium tuberculosisIsoniazidPasiniazidPara-aminosalicylic acid |